Zoster‑Associated Post‑herpetic Neuralgia (PHN)
What is Zoster‑Associated Post‑herpetic Neuralgia?
Post‑herpetic neuralgia (PHN) is a chronic nerve‑pain condition that can follow an episode of shingles (herpes zoster). After the varicella‑zoster virus reactivates in a sensory nerve ganglion, it causes the characteristic blistering rash of shingles. In some people, damage to the affected sensory nerves persists after the rash has healed, leading to persistent burning, stabbing, or electric‑shock–like pain that can last months to years. This lingering pain is what clinicians call zoster‑associated post‑herpetic neuralgia. It is a type of neuropathic pain, meaning it originates from nerve injury rather than tissue inflammation.
PHN can dramatically affect quality of life, interfering with sleep, mood, and daily activities. The risk increases with age, severe acute shingles, and a weakened immune system.
Common Causes
PHN itself is not caused by separate diseases, but it results from nerve damage triggered by specific conditions. The following factors are most often linked to the development of PHN:
- Herpes zoster (shingles) infection – the primary trigger.
- Advanced age – risk rises sharply after age 60.
- Immunosuppression – HIV/AIDS, organ transplantation, chemotherapy.
- Severe acute shingles – extensive rash, high pain scores, or involvement of the face/eye (herpes zoster ophthalmicus).
- Pre‑existing neuropathic conditions – diabetic neuropathy, peripheral neuropathy.
- Chronic skin diseases – eczema or psoriasis that disrupt skin integrity.
- Smoking – impairs immune response and nerve healing.
- Chronic stress or depression – can amplify pain perception.
- Vitamin B12 deficiency – essential for nerve health.
- Genetic predisposition – certain HLA types are associated with more severe nerve injury.
Associated Symptoms
While the hallmark of PHN is persistent pain, several other sensations and problems may accompany it:
- Allodynia – pain from light touch (e.g., clothing, a breeze).
- Hyperalgesia – exaggerated response to a painful stimulus.
- Burning or stabbing sensations that may be constant or intermittent.
- Itching or tingling (paresthesia) in the same dermatome.
- Pain that worsens at night, leading to insomnia.
- Depression, anxiety, or irritability due to chronic pain.
- Reduced range of motion if the affected area is near a joint.
- Secondary skin changes – scratching can cause excoriations or secondary infection.
When to See a Doctor
Prompt medical attention can shorten the duration of PHN and improve outcomes. Seek care if you notice any of the following:
- Severe pain that does not improve within 2–3 weeks after the shingles rash begins to heal.
- Pain that interferes with sleep, work, or daily activities.
- New or worsening numbness, weakness, or loss of sensation in the affected area.
- Signs of infection at the rash site (increased redness, swelling, purulent drainage, fever).
- Eye involvement (if shingles affected the forehead or eyelids) – this is a medical emergency.
- Any pain that is accompanied by a fever >38 °C (100.4 °F) or a spreading rash.
If you are over 50 and have never been vaccinated against shingles, discuss vaccination with your primary care provider even before a rash appears.
Diagnosis
Diagnosing PHN is primarily clinical, based on the patient’s history and physical examination. The typical steps are:
- Medical history – recent shingles episode, timing of pain onset, pain characteristics, and risk factors (age, immune status).
- Physical examination – a focused skin exam to confirm that the rash has resolved, and a neurological exam to assess sensory changes in the affected dermatome.
- Pain assessment tools – visual analogue scale (VAS), numeric rating scale (NRS), or the Neuropathic Pain Scale to gauge severity.
- Exclusion of other causes – blood tests (CBC, HbA1c, vitamin B12) or imaging (MRI, ultrasound) if the pain pattern is atypical.
- Specialist referral – to a neurologist or pain specialist for refractory cases.
There is no single laboratory test that confirms PHN; the diagnosis rests on the characteristic pattern of pain following shingles.
Treatment Options
Treatment aims to reduce pain, improve function, and prevent complications. A multimodal approach—combining medications, interventional procedures, and self‑care—offers the best results.
Pharmacologic Therapies
- Topical agents
- High‑potency lidocaine 5% patches – applied directly to the painful area for up to 12 hours/day.
- Capsaicin 8% patches – desensitize TRPV1 receptors; typically applied in a clinic under supervision.
- Anticonvulsants
- Gabapentin – start 300 mg at night, titrate to 900–1800 mg/day divided.
- Prenatal (pregabalin) – 75 mg twice daily, may be increased to 300 mg/day.
- Tricyclic antidepressants (TCAs)
- Amitriptyline – 10–25 mg at bedtime, titrated up to 75 mg as tolerated.
- Nortriptyline – similar dosing, often better tolerated.
- Serotonin‑norepinephrine reuptake inhibitors (SNRIs)
- Duloxetine 30 mg daily, may increase to 60 mg.
- Venlafaxine extended‑release 75 mg daily.
- Opioids (short‑term only)
- Consider low‑dose tramadol or hydrocodone for breakthrough pain, with strict monitoring.
- Systemic antivirals – not effective for established PHN, but essential if started within 72 hours of rash onset to reduce PHN risk (acyclovir, valacyclovir, famciclovir).
Interventional & Non‑pharmacologic Therapies
- Transcutaneous Electrical Nerve Stimulation (TENS) – may provide temporary pain relief.
- Specialized nerve blocks – e.g., stellate ganglion block for facial PHN.
- Radiofrequency ablation – targeted to the affected dorsal root ganglion for refractory pain.
- Physical therapy – gentle range‑of‑motion exercises, especially when pain limits movement.
- Cognitive‑behavioral therapy (CBT) – helps patients develop coping strategies for chronic pain.
- Complementary approaches – mindfulness meditation, acupuncture, and graded exposure to tactile stimuli.
Self‑Care & Lifestyle Strategies
- Apply cool, moist compresses to soothe the skin.
- Wear loose clothing to avoid friction that triggers allodynia.
- Maintain a regular sleep schedule; a dark, cool bedroom reduces night‑time pain.
- Stay hydrated and follow a balanced diet rich in B‑vitamins, omega‑3 fatty acids, and antioxidants.
- Limit alcohol and caffeine, which can exacerbate neuropathic pain.
Prevention Tips
The most effective way to prevent PHN is to prevent shingles or, if shingles occurs, to treat it promptly.
- Shingles vaccination – the recombinant zoster vaccine (Shingrix) is >90 % effective at preventing shingles and PHN in adults ≥50 years. Two doses, 2–6 months apart, are recommended by CDC and WHO.
- Early antiviral therapy – start valacyclovir 1 g three times daily (or equivalent) within 72 hours of rash onset to shorten the acute phase and lower PHN risk.
- Maintain immune health – regular exercise, adequate sleep, nutrition, and control of chronic diseases (diabetes, hypertension).
- Avoid smoking – cessation improves nerve healing.
- Stress management – chronic stress can reactivate varicella‑zoster; techniques such as yoga, deep‑breathing, or counseling are beneficial.
Emergency Warning Signs
- Sudden, severe pain that spreads rapidly beyond the original dermatome.
- Fever >38 °C (100.4 °F) with a worsening rash or signs of infection (redness, pus, swelling).
- Vision changes, eye redness, or facial weakness when the rash involves the forehead or eye area (possible herpes zoster ophthalmicus).
- New neurological deficits such as muscle weakness, numbness, or difficulty speaking.
- Uncontrolled bleeding or large open sores that do not begin to heal within a few days.
Key Take‑aways
- PHN is chronic nerve pain that follows shingles, most common in older adults.
- Early antiviral treatment and vaccination are the cornerstones of prevention.
- A multimodal treatment plan—topical, oral, interventional, and lifestyle measures—provides the best pain control.
- Because PHN can profoundly affect mental health, integrate psychological support into care.
- Alert for red‑flag signs (fever, eye involvement, spreading pain) and seek urgent care promptly.
For further reading, see:
- Mayo Clinic. “Postherpetic Neuralgia.” mayoclinic.org.
- CDC. “Shingles (Herpes Zoster) Vaccination.” cdc.gov.
- National Institute of Neurological Disorders and Stroke. “Postherpetic Neuralgia Information Page.” ninds.nih.gov.
- World Health Organization. “Zoster Vaccines: WHO Position Paper.” who.int.
- Cleveland Clinic. “Treatments for Postherpetic Neuralgia.” clevelandclinic.org.